GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
National Oxygen Ltd

National Oxygen Ltd approves preferential issue of 9,50,000 equity shares to promoter group

FUNDRAISE ◆ Monitor Closely MEDIUM RISK
📅 Filed on BSE: 20 Mar 2026, 06:00 PM IST  ·  BSE ID: 44e43426-0f9f-461f-ba36-56358fa7e15c
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board approved selling 9,50,000 new shares to a company owned by the promoters at a price to be set by a professional valuer.
🤖 AI Summary
  • Board approved preferential issue of 9,50,000 equity shares, face value Rs.10/- each
  • Allottee: Saraf Housing Development Private Limited, company in promoter group
  • Pricing determined by registered valuer CA S Dehaleesan per SEBI ICDR Regulations 2018
  • Separate bank account opened for preferential issue administration
  • Board approval dated 20 March 2026; meeting duration 30 minutes
🔢 Key Numbers - exact figures from BSE filing, not rounded
Equity shares approved for preferential issue
9,50,000 (Nine Lakh Fifty Thousand)
Face value per share
Rs.10/-
Allottee
Saraf Housing Development Private Limited (Promoter Group)
Valuer appointed
CA S Dehaleesan (IBBI/RV/04/2019/11659)
🏢 How This Affects the Company
💰
Financial Impact
Preferential issue to promoter group increases capital base by up to Rs. 95 lakh (at face value), strengthening balance sheet. Actual capital infusion depends on final pricing determined by registered valuer per SEBI regulations.
⚠️
Risk Impact
Related-party transaction requires shareholder approval and compliance with SEBI ICDR Regulations. Potential dilution to existing non-promoter shareholders pending valuation and allotment.
👥 What This Means For Shareholders
✅
Action Required
Watch for shareholder meeting notice seeking approval of preferential issue and related-party transaction.
👤
Who Is Affected
All existing shareholders face potential dilution. Non-promoter shareholders' ownership stake reduced upon allotment. Promoter group shareholding increases.
🔍
Management Signal
Management prioritizes capital strengthening through promoter backing rather than external fundraising, indicating confidence in existing promoter support structure.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Shareholder approval meeting notice — expected within 30 days of board date
Registered valuer pricing determination filing — will disclose actual issue price
Allotment and listing approval — track Regulation 31A(10) completion filing
MEDIUM RISK Related-party transaction requires shareholder approval. Pricing still pending valuation. Dilution risk to non-promoter shareholders if approved.
💡 Investor Takeaway
Board approved preferential allotment of 9,50,000 equity shares (face value Rs.10/- each) to promoter group company Saraf Housing Development Private Limited. Issue price to be determined by registered valuer. Shareholder approval and regulatory compliance still pending. Capital infusion amount not yet disclosed.
⚖️ Strengths & Concerns

✅ Positives

  • Capital infusion from established promoter group strengthens financial position without external debt
  • Transparent pricing mechanism: independent registered valuer determines issue price per SEBI guidelines

⚠️ Concerns

  • Related-party transaction requires shareholder approval; may dilute non-promoter shareholding
  • No pricing disclosed yet; final capital amount depends on valuer determination
📅 Company Track Record
National Oxygen Limited (CIN: L24111TN1974PLC006819) incorporated 1974. Manufactures liquid and gaseous oxygen, nitrogen, nitrous oxide, medical oxygen, and dissolved acetylene. Three manufacturing facilities in Puducherry, Erode, and Pudukottai. Previous board meeting on 17 March 2026 scheduled this preferential issue discussion.

Based on publicly available historical data. For context only.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.